To determine the in vitro inhibitory effect of experimental antibacterial substances in determinations against biodefense bacteria, including the following bacterial species: bacillus anthracis,…
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
American Type Culture Collection UEI KT4MLLHK99V6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $89,700
Award facts
- Contract value 75% obligated
- $119,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Manassas, VA 20110, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $89,700 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $119,600 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract vehicle. Under this order, the American Type Culture Collection will perform in vitro inhibitory effect determinations of experimental antibacterial substances against biodefense bacteria species including Bacillus anthracis, Yersinia pestis, Francisella tularensis, and Burkholderia m. The place of performance is the prime contractor's facility in Manassas, Virginia, with work to be completed by June 2021. This delivery order supports the NIH's research efforts to develop medical countermeasures against priority pathogens.
Description
To determine the in vitro inhibitory effect of experimental antibacterial substances in determinations against biodefense bacteria, including the following bacterial species: bacillus anthracis, yersinia pestis, francisella tularensis, burkholderia m
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to American Type Culture Collection by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 25, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $89,700 on 75N93020F00001. Its current value, with exercised options, is $119,600.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under 75N93019D00001, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award